LORINI, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 398
EU - Europa 188
AS - Asia 69
AF - Africa 3
OC - Oceania 2
Totale 660
Nazione #
US - Stati Uniti d'America 396
PL - Polonia 52
IT - Italia 40
DE - Germania 31
HK - Hong Kong 30
FI - Finlandia 18
IE - Irlanda 18
VN - Vietnam 16
CN - Cina 12
GB - Regno Unito 8
BE - Belgio 7
IN - India 6
SE - Svezia 6
UA - Ucraina 5
FR - Francia 3
CA - Canada 2
MY - Malesia 2
SG - Singapore 2
ZW - Zimbabwe 2
AU - Australia 1
AZ - Azerbaigian 1
MA - Marocco 1
NZ - Nuova Zelanda 1
Totale 660
Città #
Chandler 103
Warsaw 52
Fairfield 35
Ashburn 33
New York 32
Hong Kong 30
Princeton 26
Helsinki 18
Ann Arbor 16
Dong Ket 16
Dublin 16
Houston 14
Cambridge 12
Rome 12
Jacksonville 8
Brussels 7
Seattle 7
Shanghai 7
Woodbridge 7
Brescia 6
Pune 6
Des Moines 4
Los Angeles 4
Milan 4
Wilmington 4
Beijing 3
London 3
Augusta 2
Brooklyn 2
Frankfurt am Main 2
Kilburn 2
Mountain View 2
Nuvolento 2
Petaling Jaya 2
San Diego 2
Toronto 2
West Jordan 2
Berlin 1
Catania 1
Cittadella 1
Cleveland 1
Dallas 1
Jieyang 1
Mount Jackson 1
Norwalk 1
Pignone 1
Redwood City 1
San Francisco 1
Santa Clara 1
Singapore 1
Somma Lombardo 1
Stockholm 1
Sydney 1
Vaiano Cremasco 1
Washington 1
Totale 523
Nome #
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 109
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 96
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 85
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 62
Brain metastasis in head and neck squamous cell carcinoma after immune check point inhibitors treatment 37
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 36
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy? 35
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 33
Oral potentially malignant disorders: new insights for future treatment 33
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group 31
Confounding factors in the assessment of oral mucositis in head and neck cancer 26
Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis 22
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 19
Treatment of cutaneous squamous cell carcinoma with immune checkpoint inhibitors in special populations 19
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 17
Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis 12
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 7
Totale 679
Categoria #
all - tutte 5.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 0 0 5
2020/2021181 2 4 2 10 17 38 16 18 15 27 4 28
2021/2022119 6 18 6 4 12 10 3 6 9 7 11 27
2022/2023212 20 15 13 21 22 47 1 32 26 0 10 5
2023/2024162 9 2 22 8 11 48 9 12 29 12 0 0
Totale 679